Tectonic will be focused on advancing a pipeline of novel G-protein-coupled receptor (“GPCR”) targeted biologic therapies, including the lead program, TX45, a Fc-relaxin fusion ...

CAMBRIDGE, Mass.& WATERTOWN, Mass.---- AVROBIO, Inc. and Tectonic Therapeutic, Inc., a privately-held biotechnology company developing GPCR- targeted therapeutic proteins, co-founded by Timothy A ...

Shares of Tectonic Therapeutic (NASDAQ:TECX) plunged on Tuesday after a federal website on clinical trials indicated that Eli Lilly (NYSE:LLY) has terminated a mid-stage trial for its experimental ...

Summary. We initiate a Buy rating on Tectonic Therapeutic (NASDAQ:TECX).The company's lead candidate, TX45, which is targeting pulmonary hypertension (PH) associated with Heart Failure with ...

In One Chart ‘Tectonic shift’ to green stocks: BlackRock chart looks beyond oil and gas earnings, momentum Investor preferences for sustainable assets creates ‘great repricing’ that has ...